| Prev Close | 349.32 |
| Open | 350.64 |
| Day Low/High | 336.00 / 351.22 |
| 52 Wk Low/High | 17.91 / 178.50 |
| Volume | 10.06M |
Moderna, Inc. (MRNA)
345.64
3.68
1.05
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 401.53B |
| Market Cap | 131.90B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Biden's Spending Plan, Market Rally, Trading Nvidia, Netflix, Chipotle
Also, there's reason to turn J&J's one shot jab into a two shot vaccine just like the rest.
COVID Provides an Excuse for Selling but Watch for an Overshoot
In many respects, the Monday's action was a rerun of the standard COVID trade.
Dodging the Snakes, Dissonant Dance With China, Dipping Into the Chip Bowl
Those rattles you hear on the COVID, Fed and political fronts are reasons to tread carefully in the markets.
Jim Cramer: Let's Give Taiwan a Needed Shot in the Arm
Here's how the U.S. can play a critical part in defending the island from COVID -- and mainland China.
Take a Jab at Moderna, but Be Guarded for Any Adverse Reactions
Moderna has been a winner, but here's why traders should raise stops.
Jim Cramer: Nasdaq's Big Second-Quarter Winners Were Written Off Too Soon
These companies were counted out way too early in the post-pandemic environment and the sellers are experiencing some real regret.
U.S. Dollar, Gold, Bitcoin, Home Prices, SpaceX, Intel's Delays, Moderna Vaccine
The greenback has maintained a higher level of relative strength versus its peer reserve currencies than I would have thought.
Uncertain Fiscal Policy, FOMC, Virus X Factor, Copper, United Rentals Stock
There's a split growing at the FOMC as to just how transitory the current burst of consumer level inflation actually is.
Bearish Bets: 2 Downgraded Stocks You Should Consider Shorting This Week
These names are displaying both quantitative and technical deterioration.
CureVac Is Down But Not Out: Here's How to Trade It
CVAC is now working on a 'next generation' COVID-19 vaccine candidate with GlaxoSmithKline.
Jim Cramer: I Warned You That Betting Against Science Is a Mug's Game
And I was right, and the cynics were wrong. Here's why that matters more than ever now.
If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It
I prefer the bear put spread over the covered equity play due to the decreased risk to principal, despite the capped potential for profit.
Moderna's Charts Are Bullish and Pointed Higher
Here's the area where I would like to go long MRNA.
Jobs Data Flim Flam, AMC Matinee Trading, 2 Breakout Candidates, Wake Up, Fed
Plus, it appears there may be headway on an infrastructure bill that could work for both sides of the aisle.
Jim Cramer: Disbelief in Science vs. COVID Shares Blame for Supply Shortages
We've been caught with our pants down, largely because we had no faith in the smartest people in the country.
Moderna Could Provide a 'Shot in the Arm' for Your Portfolio
Debt-free and poised to gain from its COVID-19 vaccine demand, MRNA could inject some life into your investment plan.
A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care
The market seems to rejoice from the latest mask utterance out of the CDC, but the action at the Nasdaq should give traders pause.
In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment
ARCT's IP is incredibly valuable, and may in fact be invaluable.
ARKK Under Pressure, Peloton, Vaccine Moral Dilemma, Charting the Nasdaq
The fund is at a key spot technically, and there is real fear that if this spot cracks, what looks like a stretch of rough rapids could become a waterfall.
Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?
UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.
Bank Earnings, Late Day Market Surges, Vaccine Update, Trading Coinbase
Perhaps the most interesting result of an inflationary but not frightening CPI was visible in U.S. Treasury security markets.
Jim Cramer: Johnson & Johnson? Moderna and Pfizer Can Do the Job
You never want to be caught in a counter trend rally.
I'm Not Bailing on Johnson & Johnson Now
Don't forget, this is a very large company with a lot more than the vaccine going on.
Jim Cramer: We're Seeing the Triumph of Big Balance Sheets vs the Small Ones
I would argue that the pandemic has lasted just long enough to wipe out the little guy and let the bigger guys have the run of the joint.
I'm Buying Arcturus Therapeutics Stock and Here's the Reason Why
My COVID vaccine eligibility actually began about a week before my symptoms began.
For Now I'm Sticking With More Boring Names With Good Setups Like AT&T
A buy-write makes sense here, but the premiums are tight, so I'd rather do a buy-ratio spread.
Jim Cramer: It's Time for Clear COVID Rules That Make Sense
Outside of the pro sports world, it seems like amateur hour with regard to protocols.
Should You Buy AstraZeneca After Its Positive Vaccine News?
Here's my view on this space and where the money is to be made.
